Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | NQO1 | P15559 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.51 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31714520 | 1.00 | MEN1 (0.56) | MEN1KMT2ANPC1APOBEC3GALDH1A1 | |
| SCHEMBL4227827 | 0.84 | MAPT (0.57) | MEN1KMT2ANPC1ALDH1A1MAPT | |
| SCHEMBL4610819 | 0.83 | MEN1 (0.61) | MEN1KMT2ANPC1APOBEC3GALDH1A1 | |
| SCHEMBL5952240 | 0.83 | MEN1 (0.66) | MEN1KMT2ANPC1APOBEC3GALDH1A1 | |
| SCHEMBL30646246 | 0.83 | MEN1 (0.66) | MEN1KMT2ANPC1APOBEC3GALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL9517722 | 0.81 | MEN1 (0.63) | MEN1KMT2ANPC1APOBEC3GALDH1A1 | |
| Hydrochloric Acid SCHEMBL11702133 | 0.81 | MEN1 (0.63) | MEN1KMT2ANPC1APOBEC3GALDH1A1 | |
| SCHEMBL10984116 | 0.81 | KMT2A (0.42) | MEN1KMT2ANPC1APOBEC3GALDH1A1 | |
| SCHEMBL143430 | 0.80 | NQO1 (0.59) | MEN1KMT2ANPC1APOBEC3GALDH1A1 | |
| SCHEMBL17978454 | 0.80 | ALDH1A1 (0.43) | MEN1KMT2ANPC1APOBEC3GALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109438683-A | A kind of polyester elastomer and preparation method thereof | 温州大学 | 2019-03-08 | — | — | CN | claimed |
| US-20250333414-A1 | HETARYL SUBSTITUTED INDAZOLES AND BENZIMIDAZOLES AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2025-10-30 | — | — | US | disclosed |
| EP-3408332-B1 | BIS-AZO COLORANTS FOR USE AS BLUING AGENTS | MILLIKEN & CO (US) | 2022-03-23 | — | — | EP | disclosed |
| EP-3408368-B1 | BIS-AZO COLORANTS FOR USE AS BLUING AGENTS | PROCTER & GAMBLE (US) | 2021-10-13 | — | — | EP | disclosed |
| US-11078366-B2 | Bis-azo colorants for use as bluing agents | MILLIKEN & COMPANY (US) | 2021-08-03 | — | — | US | disclosed |
| CN-111548649-B | Disazo colorants for use as bluing agents | 美利肯公司 | 2021-07-06 | — | — | CN | disclosed |
| CN-111548649-A | Disazo colorants for use as bluing agents | 美利肯公司 | 2020-08-18 | — | — | CN | disclosed |
| US-20200164084-A1 | ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBINATION THERAPIES | NOVARTIS AG (CH) | 2020-05-28 | — | — | US | disclosed |
| CN-108473788-B | Disazo colorants for use as bluing agents | 美利肯公司 | 2020-05-01 | — | — | CN | disclosed |
| US-10633543-B2 | Bis-azo colorants for use as bluing agents | MILLIKEN & COMPANY (US) | 2020-04-28 | — | — | US | disclosed |
| EP-0065811-B1 | DISPERSE AZOPYRIMIDINE DYESTUFFS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-01-02 | — | — | EP | disclosed |
| EP-0065811-A1 | Disperse azopyrimidine dyestuffs | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-12-01 | — | — | EP | disclosed |
| US-4083844-A | Phenylazo orthocyano phenylazo or orthocyano phenylazo phenylazo containing dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-11 | — | — | US | disclosed |
| US-4036824-A | Disazo dyestuffs containing A-O-alkylene-O-SO3 H group | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | disclosed |
| US-4024126-A | FASTNESS PROPERTIES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
| US-4022763-A | Sulfaphenyl-azo-phenyl-azo-aminophenyl dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-10 | — | — | US | disclosed |
| US-4008216-A | WOOL, POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-15 | — | — | US | disclosed |
| US-3971770-A | Disulfimide disazo dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | disclosed |
| US-3956267-A | Indole-containing disazo dyestuffs having a sulfatoalkyleneoxy-substituent | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3945992-A | DISAZO DYES FOR POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333414-A1 | HETARYL SUBSTITUTED INDAZOLES AND BENZIMIDAZOLES AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT | STING1, MAVS, TBK1 | MEN1 1800/4885KMT2A 3850/4885NPC1 531/4885 |
| US-20200164084-A1 | ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBINATION THERAPIES | TLR3, TLR2, TLR9 | MEN1 4325/4885KMT2A 246/4885NPC1 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.